Trade PCRX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Pacira BioSciences, Inc. (PCRX) is trading at US$25.53, up 1.27% today as of Oct 5, 10:53 EDT. The company has a market capitalisation of US$983.39M. Over the past 52 weeks, PCRX has traded between US$18.80 and US$27.66. On Syfe you can trade PCRX with $0 commission and add it to your watchlist.
| Previous close | US$25.21 |
|---|---|
| Market cap | US$983.39M |
| P/E ratio | 7.72 |
| 52-week range | US$18.80 – US$27.66 |
| Volume | 469.8K |
| Exchange | US |
Pacira BioSciences, Inc.
Pacira Biosciences, Inc. is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam. The company was founded in December 2006 and is headquartered in Brisbane, CA.
Year: 2011
RBC Adjusts Price Target on Pacira Biosciences to $25 From $24, Maintains Sector Perform Rating
Aug 5, 12:36 PM · MT Newswires
-- Earnings Flash (PCRX) Pacira BioSciences, Inc. Posts Q2 Adjusted EPS $0.73 per Share, vs. FactSet Est of $0.65
Aug 4, 8:15 PM · MT Newswires
Pacira BioSciences, Inc. (PCRX) stock is trading at US$25.53, +1.27% from the previous close of US$25.21.
The market cap for Pacira BioSciences, Inc. (PCRX) stock is approximately US$983.39M.
The price-to-earnings ratio for Pacira BioSciences, Inc. (PCRX) is 7.72, based on the latest reported earnings.
The 52-week high for Pacira BioSciences, Inc. (PCRX) stock is US$27.66.
The 52-week low for Pacira BioSciences, Inc. (PCRX) stock is US$18.80.
Pacira BioSciences, Inc. (PCRX) does not currently pay a dividend.
Stay on top of PCRX
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
